Trials / Completed
CompletedNCT02683226
Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University Medical Centre Ljubljana · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to determine whether dual treatment with metformin and alogliptin is more effective than treatment with metformin, alogliptin and pioglitazone in the treatment of obese women with polycystic ovary syndrome (PCOS) regarding insulin resistance and beta cell function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vipdomet | |
| DRUG | Incresync |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2015-06-01
- Completion
- 2015-07-01
- First posted
- 2016-02-17
- Last updated
- 2016-05-11
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT02683226. Inclusion in this directory is not an endorsement.